SCHEMBL30782878

SCHEMBL30782878

CNCC1OCCc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.60
ALDH1A1 P00352 5/20 0.58
KMT2A Q03164 3/20 0.58
LMNA P02545 1/20 0.58
TSHR P16473 2/20 0.57
GAA P10253 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
RECQL P46063 1/20 0.57
HTR1A P08908 1/20 0.55
DRD2 P14416 1/20 0.55
HTR7 P34969 1/20 0.55
MAPT P10636 4/20 0.54
MEN1 O00255 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
BLM P54132 1/20 0.54
XBP1 P17861 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14452010 1.00 TAAR1 (0.60) TAAR1ALDH1A1KMT2ALMNATSHR
SCHEMBL8276903 0.84 TSHR (0.61) ALDH1A1KMT2ALMNATSHRGAA
SCHEMBL19258004 0.83 ALDH1A1 (0.58) TAAR1ALDH1A1KMT2ALMNATSHR
SCHEMBL14438274 0.83 ALDH1A1 (0.54) ALDH1A1KMT2ALMNATSHRGAA
SCHEMBL20031046 0.81 TSHR (0.59) ALDH1A1KMT2ALMNATSHRGAA
SCHEMBL20031062 0.81 TSHR (0.59) ALDH1A1KMT2ALMNATSHRGAA
SCHEMBL13197463 0.81 ALDH1A1 (0.51) TAAR1ALDH1A1KMT2ALMNATSHR
SCHEMBL15286987 0.81 ALDH1A1 (0.56) TAAR1ALDH1A1KMT2ALMNATSHR
SCHEMBL19821145 0.80 TAAR1 (0.56) TAAR1ALDH1A1KMT2ALMNATSHR
SCHEMBL19821147 0.80 TAAR1 (0.56) TAAR1ALDH1A1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4593954-A1 COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER PGI Drug Discovery LLC (US) 2025-08-06 EP disclosed
WO-2024073383-A1 COMPOUNDS FOR THE TREATMENT OF A CENTRAL NERVOUS SYSTEM DISEASE OR DISORDER PGI DRUG DISCOVERY LLC (US) 2024-04-04 WO disclosed